[1]王中英,Xiang,Fang.糖尿病脑病与胰岛素抵抗关系的研究进展[J].国际内分泌代谢杂志,2021,41(05):463-467.[doi:10.3760/cma.j.cn121383-20200823-08039]
 Wang Zhongying,Xiang Fang..Current progress on diabetic encephalopathy and insulin resistance[J].International Journal of Endocrinology and Metabolism,2021,41(05):463-467.[doi:10.3760/cma.j.cn121383-20200823-08039]
点击复制

糖尿病脑病与胰岛素抵抗关系的研究进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年05期
页码:
463-467
栏目:
综述
出版日期:
2021-09-30

文章信息/Info

Title:
Current progress on diabetic encephalopathy and insulin resistance
作者:
王中英1XiangFang2
1菏泽医学专科学校内科学教研室 274000; 2美国德克萨斯大学医学院,加尔维斯顿 77555
Author(s):
Wang Zhongying1 Xiang Fang2.
1Department of Internal Medicine, Heze Medical College, Heze 274000, China; 2University of Texas Medical Branch, Galveston 77555, USA
关键词:
糖尿病脑病 2型糖尿病 胰岛素抵抗 蛋白质错误折叠
Keywords:
Diabetic encephalopathy Type 2 diabetes mellitus Insulin resistance Protein misfolding
DOI:
10.3760/cma.j.cn121383-20200823-08039
摘要:
胰岛素抵抗是2型糖尿病的标志,胰岛素信号在大脑功能的建立和维持中发挥重要作用。糖尿病脑病是糖尿病并发症之一,与阿尔茨海默病一样与大脑胰岛素抵抗密切相关。同为异质性失调,两者的核心特征均是胰岛素信号不同节点的异常,涉及胰岛素分子与受体的结合、胰岛素受体的自磷酸化激活、受体底物的活化及胞内信号的转导和调控。而且,二者与蛋白质错误折叠、形成异常构象的淀粉样不溶性聚集物密切相关,其共同的病理表现为Aβ的沉积和Tau蛋白过度磷酸化。越来越多的事实证明,胰岛素原构象的改变、胰岛素受体受损及胰岛淀粉样多肽生成,在糖尿病脑病的发生发展中具有重要作用。蛋白质稳态概念的提出,为2型糖尿病与阿尔茨海默病一样作为一种蛋白质错误折叠病,开启了胰岛素抵抗研究的全新领域。
Abstract:
Insulin resistance is the hallmark of type 2 diabetes. Insulin signaling plays an important role in the establishment and maintenance of brain function. As one of the end organ complications of diabetes, diabetic encephalopathy is closely related with insulin resistance in the brain just like Alzheimer's disease. Diabetic encephalopathy and Alzheimer's disease are heterogeneous disorders, and the core characteristics of these disorders are related to abnormal insulin signaling involved in multiple steps such as binding of insulin molecules to receptors, autophosphorylation activation of insulin receptors, activation of insulin receptor substrates, and intracellular signal transduction and regulation. Furthermore, they are closely related to protein misfolding and abnormal amyloid insoluble aggregates. In addition, their common pathological manifestations are deposition of amyloid β-protein(Aβ)and Tau hyperphosphorylation. There are accumulating evidences show that the alteration of the conformation of proinsulin, the damage of insulin receptor and the production of islet amyloid polypeptide(IAPP)play important roles in occurrence and progression of diabetic encephalopathy. The concept of protein homeostasis, which believes type 2 diabetes is a protein misfolding disease(PMD)like Alzheimer's disease, provides a novel approach for insulin resistance research.

参考文献/References:

[1] Leszek J,Trypka E,Tarasov VV,et al.Type 3 diabetes mellitus: a novel implication of Alzheimers disease[J].Curr Top Med Chem,2017,17(12):1331-1335.DOI:10.2174/1568026617666170103163403.
[2] Rani L,Mittal J,Mallajosyula SS.Effect of phosphorylation and O-GlcNAcylation on Proline-Rich domains of Tau[J].J Phys Chem B,2020,124(10):1909-1918.DOI:10.1021/acs.jpcb.9b11720.
[3] Grillo CA,Piroli GG,Lawrence RC,et al.Hippocampal insulin resistance impairs spatial learning and synaptic plasticity[J].Diabetes,2015,64(11):3927-3936.DOI:10.2337/db15-0596.
[4] Grillo CA,Woodruff JL,Macht VA,et al.Insulin resistance and hippocampal dysfunction:disentangling peripheral and brain causes from consequences[J].Exp Neurol,2019,318:71-77.DOI:10.1016/j.expneurol.2019.04.012.
[5] Craft S,Raman R,Chow TW,et al.Safety,efficacy,and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia:a randomized clinical trial[J].JAMA Neurol,2020,77(9):1099-1109.DOI:10.1001/jamaneurol.2020.1840.
[6] Mustapic M,Tran J,Craft S,et al.Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer's Disease[J].J Alzheimers Dis,2019,69(2):489-498.DOI:10.3233/JAD-180578.
[7] Zhao N,Liu CC,Van Ingelgom AJ,et al.Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes[J].Neuron,2017,96(1):115-129.e5.DOI:10.1016/j.neuron.2017.09.003.
[8] 朱丹,蔡可英,曹萌,等.胰岛素原稳态与胰岛β细胞功能[J].内分泌与代谢疾病,2015,35(2):110-113.DOI:10.3760/cma.j.issn.1673-4157.2015.02.010.
[9] Arunagiri A,Haataja L,Pottekat A,et al.Proinsulin misfolding is an early event in the progression to type 2 diabetes[J].Elife,2019,8:e44532.DOI:10.7554/eLife.44532.
[10] Lee HK,Kwon B,Lemere CA,et al.mTORC2(Rictor)in Alzheimer's Disease and reversal of Amyloid-β expression-induced insulin resistance and toxicity in rat primary cortical neurons[J].J Alzheimers Dis,2017,56(3):1015-1036.DOI:10.3233/JAD-161029.
[11] He YX,Shen QY,Tian JH,et al.Zonisamide ameliorates cognitive impairment by inhibiting ER stress in a mouse model of type 2 diabetes mellitus[J].Front Aging Neurosci,2020,12:192.DOI:10.3389/fnagi.2020.00192.
[12] De Felice FG,Lourenco MV,Ferreira ST.How does brain insulin resistance develop in Alzheimer's disease? [J].Alzheimers Dement,2014,10(1Suppl):S26-32.DOI:10.1016/j.jalz.2013.12.004.
[13] Liu S,Li X,Yang J,et al.Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in β cells[J].FASEB J,2019,33(10):11338-11348.DOI:10.1096/fj.201900442R.
[14] De Felice FG,Benedict C.A key role of insulin receptors in memory[J].Diabetes,2015,64(11):3653-3655.DOI:10.2337/dbi15-0011.
[15] Folch J,Ettcheto M,Busquets O,et al.The implication of the brain insulin receptor in late onset Alzheimer's disease dementia[J].Pharmaceuticals(Basel),2018,11(1):11.DOI:10.3390/ph11010011.
[16] Ren B,Zhang Y,Zhang M,et al.Fundamentals of cross-seeding of amyloid proteins:an introduction[J].J Mater Chem B,2019,7(46):7267-7282.DOI:10.1039/c9tb01871a.
[17] de la Monte SM.Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease[J].Curr Alzheimer Res,2012,9(1):35-66.DOI:10.2174/156720512799015037.
[18] Mukherjee A,Morales-Scheihing D,Butler PC,et al.Type 2 diabetes as a protein misfolding disease[J].Trends Mol Med,2015,21(7):439-449.DOI:10.1016/j.molmed.2015.04.00
[19] Di Domenico F,Barone E,Perluigi M,et al.The triangle of death in Alzheimer's disease brain:the aberrant cross-talk among energy metabolism,mammalian target of rapamycin signaling,and protein homeostasis revealed by redox proteomics[J].Antioxid Redox Signal,2017,26(8):364-387.DOI:10.1089/ars.2016.6759.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(05):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(05):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(05):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(05):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(05):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(05):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
基金项目:山东省卫生健康委员会出国留学项目及NIA AG069226项目
通信作者:王中英,Email:3098969168@qq.com
更新日期/Last Update: 2021-10-10